IQVIA said revenue for Q1 2025 was $3,829 million, up 2.5% on a reported basis and 3.5% at constant currency compared to the prior-year quarter. Technology & Analytics Solutions revenue was $1,546 million, up 6.4% on a reported basis, and Research & Development Solutions revenue was $2,102 million, up 0.3%.

1. 01

   IQVIA said revenue for Q1 2025 was $3,829 million, up 2.5% on a reported basis and 3.5% at constant currency compared to the prior-year quarter. Technology & Analytics Solutions revenue was $1,546 million, up 6.4% on a reported basis, and Research & Development Solutions revenue was $2,102 million, up 0.3%.

2. 02

   The company said GAAP net income for Q1 2025 was $249 million, or $1.40 diluted per share, and Adjusted EBITDA was $883 million, up 2.4% year-over-year. Adjusted diluted earnings per share were $2.70, up 6.3%.

3. 03

   IQVIA said operating cash flow for Q1 2025 was $568 million and free cash flow was $426 million. The company repurchased $425 million of common stock in the quarter, and as of March 31, 2025 had $2,588 million of share repurchase authorization remaining.

4. 04

   The company raised its full-year 2025 revenue guidance to $16,000 million to $16,400 million to reflect favorable foreign currency exchange rate changes since its prior guidance, it said. It reaffirmed its Adjusted EBITDA guidance of $3,765 million to $3,885 million and Adjusted diluted earnings per share guidance of $11.70 to $12.10.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.